4.6 Review

Thematic Review Series: Lipid Droplet Synthesis and Metabolism: from Yeast to Man Seipin: from human disease to molecular mechanism

Journal

JOURNAL OF LIPID RESEARCH
Volume 53, Issue 6, Pages 1042-1055

Publisher

ELSEVIER
DOI: 10.1194/jlr.R023754

Keywords

congenital generalized lipodystrophy; lipodystrophy; Berardinelli-Seip congenital lipodystrophy; lipid droplet; adipogenesis

Funding

  1. National Institutes of Health [5T32-GM-008203, R01 GM-084210]

Ask authors/readers for more resources

The most-severe form of congenital generalized lipodystrophy (CGL) is caused by mutations in BSCL2/seipin. Seipin is a homo-oligomeric integral membrane protein in the endoplasmic reticulum that concentrates at junctions with cytoplasmic lipid droplets (LDs). While null mutations in seipin are responsible for lipodystrophy, dominant mutations cause peripheral neuropathy and other nervous system pathologies. We first review the clinical aspects of CGL and the discovery of the responsible genetic loci. The structure of seipin, its normal isoforms, and mutations found in patients are then presented. While the function of seipin is not clear, seipin gene manipulation in yeast, flies, mice, and human cells has recently yielded a trove of information that suggests roles in lipid metabolism and LD assembly and maintenance. A model is presented that attempts to bridge these new data to understand the role of this fascinating protein.-Cartwright, B. R. and J. M. Goodman. Seipin: from human disease to molecular mechanism. J. Lipid Res. 2012. 53: 1042-1055.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available